Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Virology|August 14, 2015
Induction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral TherapyAlexander J Gill, Colleen E Kovacsics, Patricia J Vance, et al.
Journal of Neurovirology|September 10, 2020
Neuroinflammation associates with antioxidant heme oxygenase-1 response throughout the brain in persons living with HIVAnalise L Gruenewald, Yoelvis Garcia-Mesa, Alexander J Gill, et al.
Brain and Behavior|May 14, 2026
The Effect of Ocrelizumab on Anti-JC Virus Antibody IndexAkash Virupakshaiah, Alexander J Gill, Vinicius A Schoeps, et al.
The Journal of Clinical Investigation|September 10, 2014
Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disordersAlexander J Gill, Colleen E Kovacsics, Stephanie A Cross, et al.
Antioxidants (Basel, Switzerland)|April 3, 2021
Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV NeuroprotectionYoelvis Garcia-Mesa, He N Xu, Patricia Vance, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 12, 2020
Heme oxygenase-1 promoter (GT) <sub></sub> polymorphism associates with HIV neurocognitive impairmentRolando Garza, Alexander J Gill, Brandon L Bastien, et al.
Frontiers in Molecular Neuroscience|May 23, 2022
Reactive Astrocytes Derived From Human Induced Pluripotent Stem Cells Suppress Oligodendrocyte Precursor Cell DifferentiationMatthew D Smith, Xitiz Chamling, Alexander J Gill, et al.
Journal of Neuroinflammation|January 28, 2025
NLRX1 limits inflammatory neurodegeneration in the anterior visual pathwayAlexander J Gill, Matthew D Smith, Danny Galleguillos, et al.
Nature Neuroscience|February 17, 2026
Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatosJackson W Mace, Sachin P Gadani, Matthew D Smith, et al.
Neurology|November 14, 2024
Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic IndicationsCarson M Quinn, Prashanth Rajarajan, Alexander J Gill, et al.
Pageof 3